Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B XNAS: LGND

Expensive Performer

106.22 -3.73 (-3.39%)

56.85% Gain from 52W Low

128.6K XNAS Volume

XNAS 18 Mar, 2025 4:03 PM (EDT)

Detailed Stock Analysis for Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B with Real-time Stock Report